Aspen Neuroscience was incorporated on May 18, 2018, in Delaware.
10835 Road to the Cure, Ste. 100, San Diego, CA 92121.
Our common stock first began trading on NASDAQ Capital Markets in October 2026 under the ticker symbol “ASPE.”
Aspen does not currently offer a direct stock purchase plan.
No. Because we do not currently pay dividends, we do not offer a dividend reinvestment plan.
044933109
Odyssey Transfer and Trust Company
860 Blue Gentian Rd, Suite 320
Eagan, MN 55121
Online:
https://odysseytrust.com/us/contact-us/
Phone:
Toll-Free (U.S. & Canada): 1-888-290-1175
Direct Dial (All Regions): 1-612-482-5100
Our independent auditor is Ernst & Young LLP.
Aspen Neuroscience’s fiscal year ends December 31.
Aspen Neuroscience’s press release archive can be viewed under the “Press Releases” section of the Investor Relations website at ir.aspenneuroscience.com.
Aspen Neuroscience’s SEC filings can be found on www.sec.gov and are also available under the “SEC Filings” section of the Investor Relations website at ir.aspenneuroscience.com.
You may email questions to ir@aspenneuro.com.
You may automatically receive Aspen Neuroscience’s news and SEC filings by email by signing up for Email Alerts.